RecallDepth
Class II Terminated

Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01), packaged in 1 mL x 5 Single Dose Vials per carton (NDC 42023-179-05), Rx Only, Distributed by: Par Pharmaceuticals Companies, Inc., Spring Valley, NY 10977.

Company
Par Sterile Products Llc
Recall Initiated
April 28, 2017
Posted
May 17, 2017
Recall Number
D-0698-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
122,469 cartons
Firm Location
Rochester, MI, United States

Reason for Recall

Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 821102, 821103, Exp 01/18; 821104, 821106, 821107, Exp 02/18; 821108, Exp 03/18; 821884, 821885, Exp 07/18; 821886, 821887, Exp 08/18; 822767, Exp 09/18; 824183, Exp 10/18.

More recalls by Par Sterile Products Llc

View all recalls by this company →

Other recent Class II Drug recalls